Use of antiretroviral therapy among HIV positive individuals living in British Columbia

References

• Blankson , JN and Silicisno , RF . 2001 . Structured therapeutic interruptions: a review . Hopkins HIV Report , 13 : 8 – 9 .
   Google Scholar
• British Columbia Centre for Disease Control Society: STD/AIDS Control 2001 HIV/AIDS update: annual 2001 Vancouver BC Centre for Disease Control
   Google Scholar
• Celentano , DD , Galai , N , Sethi , AK , Shah , NG , Strathdee , SA , Vlahov , D and Gallant , JE . 2001 . Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users . AIDS , 15 : 1707 – 1715 .
   PubMed Web of Science ®Google Scholar
• Davies , AG , Cormack , RM and Richardson , AM . 1999 . Estimation of injecting drug users in the city of Edinburgh, Scotland, and number infected with human immunodeficiency virus . International Journal of Epidemiology , 28 : 117 – 121 .
   PubMed Web of Science ®Google Scholar
• Desclaux , A , Ciss , M , Tavern , B , Sow , PS , Egrot , M , Faye , MA , Laniece , I , Sylla , O , Delaporte , E and Ndoye , I . 2003 . Access to antiretroviral drugs and AIDS management in Senegal . AIDS , 17 : S95 – S101 .
   PubMed Web of Science ®Google Scholar
• Detels , R , Munoz , A , McFarlane , G , Kingsley , LA , Margolick , J , Giorgi , J , Schrager , LK , Phair , JP and for the MACS Investigators . 1998 . Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration . Journal of the American Medical Association , 280 : 1497 – 1503 .
   PubMed Web of Science ®Google Scholar
• Graham , NM , Jacobson , LP , Kuo , V , Chmiel , JS , Morgenstern , H and Zucconi , SL . 1994 . Access to therapy in the Multicenter AIDS Cohort Study, 1989–1992 . Journal of Clinical Epidemiology , 47 : 1003 – 1012 .
   PubMed Web of Science ®Google Scholar
• Heath , KV , Singer , J , O'Shaughnessy , MV , Montaner , JS and Hogg , RS . 2002 . Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy . Journal of Acquired Immune Deficiency Syndromes , 31 : 211 – 217 .
   PubMed Web of Science ®Google Scholar
• Heath , KV , Montaner , JS , Bondy , G , Singer , J , O'Shaughnessy , MV and Hogg , RS . 2003 . Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection . Current Drug Targets , 4 : 13 – 22 .
   PubMed Web of Science ®Google Scholar
• Hogg , RS , O'Shaughnessy , MV , Gataric , N , Yip , B , Craib , K , Schechter , MT and Montaner , JS . 1997 . Decline in deaths from AIDS due to new antiretrovirals . Lancet , 349 : 1294
   PubMed Web of Science ®Google Scholar
• Hogg , RS , Havlir , D , Miller , V and Montaner , JS . 2002 . To stop or not to stop: that is the question, but what is the answer? . AIDS , 16 : 787 – 789 .
   PubMed Web of Science ®Google Scholar
• Judd , A , Hunter , GM , Maconochie , N , Hickman , M , Parry , JV , Renton , AM and Stimson , GV . 1999 . HIV prevalence and risk behaviour among female injecting drug users in London, 1990 to 1996 . AIDS , 13 : 833 – 837 .
   PubMed Web of Science ®Google Scholar
• Kang , E , Rapkin , BD , Springer , C and Kim , JH . 2003 . The ‘demon plague’ and access to care among Asian undocumented immigrants living with HIV disease in New York City . Journal of Immigrant Health , 5 : 49 – 58 .
   PubMedGoogle Scholar
• Kaufmann , GR , Smith , D , Bucher , HC , Phanuphak , P , Sendi , PP , Mbidde , EK , Cooper , DA and Battegay , M . 2002 . Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries . Expert Opinion on Investigative Drugs , 11 : 1303 – 1313 .
   PubMed Web of Science ®Google Scholar
• Low-Beer , S , Bartholomew , K , Weber , AE , Chan , K , Landolt , M , Oram , D , Schilder , A and Hogg , R . 2002 . A demographic and health profile of gay and bisexual men in a large Canadian urban setting . AIDS Care , 14 : 111 – 115 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A , Gill , MJ , Davidson , W and Phillips , AN . 2000 . Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? . Journal of Acquired Immune Deficiency Syndromes , 24 : 475 – 482 .
   PubMed Web of Science ®Google Scholar
• Moore , RD and Chaisson , RE . 1999 . Natural history of HIV infection in the era of combination antiretroviral therapy . AIDS , 13 : 1933 – 1942 .
   PubMed Web of Science ®Google Scholar
• Msellati , P , Juillet-Amari , A , Prudhomme , J , Akribi , HA , Coulibaly-Traore , D , Souville , M and Moatti , JP . 2003 . Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Cote d'Ivoire . AIDS , 17 : S63 – S68 .
   PubMed Web of Science ®Google Scholar
• Murri , R , Lepri , AC , Phillips , AN , Girardi , E , Nasti , G , Ferrara , S , Mura , MS , Mussini , C , Petrelli , E , Arlotti , M , De Stefano , C , Vigano , P , Novati , R , Cargnel , A and Monforte , AD . 2003 . Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of cinical events according to sex: evidence from the I.Co.N.A. study . Journal of Acquired Immune Deficiency Syndromes , 34 : 184 – 190 .
   PubMed Web of Science ®Google Scholar
• Nguyen , VK , Grennan , T , Peschard , K , Tan , D and Tiendrebeogo , I . 2003 . Antiretroviral use in Ouagadougou, Burkina Faso . AIDS , 17 : S109 – S111 .
   PubMed Web of Science ®Google Scholar
• Schilder AJ Hogg RS Perry T Goldstone I O'Shaughnessy MV 1999 Level and determinants of antiretroviral use in the province of British Columbia (abstract) Paper presented at the 12th Annual Canadian Conference for HIV Research Halifax Nova Scotia April 10–13
   Google Scholar
• Smith , SR and Buchanan , RJ . 2001 . The AIDS drug assistance programs and coverage of HIV-related medications . Annals of Pharmacotherapy , 35 : 155 – 166 .
   PubMed Web of Science ®Google Scholar
• Smith , SR and Kirking , DM . 1999 . Access and use of medications in HIV disease . Health Services Research , 34 : 123 – 144 .
   PubMed Web of Science ®Google Scholar
• Smith , SR and Kirking , DM . 2001 . The effect of insurance coverage changes on drug utilization in HIV disease . Journal of Acquired Immune Deficiency Syndromes , 28 : 140 – 149 .
   PubMed Web of Science ®Google Scholar
• Solomon , L , Stein , M , Flynn , C , Schuman , P , Schoenbaum , E , Moore , J , Holmberg , S and Graham , NM . 1998 . Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS) . Journal of Acquired Immune Deficiency Syndromes , 17 : 253 – 261 .
   Web of Science ®Google Scholar
• Staehelin , C , Rickenbach , M , Low , N , Egger , M , Ledergerber , B , Hirschel , B , D'Acremont , V , Battegay , M , Wagels , T , Bernasconi , E , Kopp , C and Furrer , H . 2003 . Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival . AIDS , 17 : 2237 – 2244 .
   PubMed Web of Science ®Google Scholar
• Strathdee , SA , Palepu , A , Cornelisse , PG , Yip , B , O'Shaughnessy , MV , Montaner , JS , Schechter , MT and Hogg , RS . 1998 . Barriers to use of free antiretroviral therapy in injection drug users . Journal of the American Medical Association , 280 : 547 – 549 .
   PubMed Web of Science ®Google Scholar
• Vlahov , D , Safaien , M , Lai , S , Strathdee , SA , Johnson , L , Sterling , T and Celentano , DD . 2001 . Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users . AIDS , 15 : 2311 – 2316 .
   PubMed Web of Science ®Google Scholar
• Wood , E , Montaner , JS , Chan , K , Tyndall , MW , Schechter , MT , Bangsberg , D , O'Shaughnessy , MV and Hogg , RS . 2002 . Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996 . AIDS , 16 : 2065 – 2072 .
   PubMed Web of Science ®Google Scholar
• Wood , E , Montaner , J , Bangsberg , D , Tyndall , M , Strathdee , S , O'Shaughnessy , M and Hogg , R . 2003a . Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world . AIDS , 17 : 2419 – 2427 .
   PubMed Web of Science ®Google Scholar
• Wood , E , Montaner , J , Tyndall , M , Schechter , M , O'Shaughnessy , M and Hogg , R . 2003b . Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy . Journal of Infectious Disease , 188 : 1164 – 1170 .
   PubMed Web of Science ®Google Scholar